The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.

Documenti analoghi

• The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
  di: Trist, D. G., et al.
  Pubblicazione: (1989)
• Classification of platelet and vascular prostaglandin D2 (DP) receptors: estimation of affinities and relative efficacies for a series of novel bicyclic ligands. With an appendix on goodness-of-fit analyses.
  di: Leff, P., et al.
  Pubblicazione: (1992)
• The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
  di: Hamid-Bloomfield, S., et al.
  Pubblicazione: (1990)
• Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
  di: Hamid-Bloomfield, S., et al.
  Pubblicazione: (1989)
• Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand
  di: Sharif, N A, et al.
  Pubblicazione: (2000)